Countouriotis Athena (CIK 0001571469)

Latest company ownership

PASG - Passage BIO, Inc.
Role: Director
Shares held
47,693
Last filed at
May 23, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
HALO - HALOZYME THERAPEUTICS, INC.
Role: SVP and Chief Medical Officer
Shares held
18,496
Last filed at
Feb 6, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 24, 2020 Mar 25, 2020 Passage BIO, Inc. Director Buy 95.0 +10,000 112.36% ✗ $149.8K
Mar 3, 2020 Mar 3, 2020 Passage BIO, Inc. Director Buy 95.0 +8,900 100.00% ✗ $160.2K
Feb 3, 2017 Feb 6, 2017 HALOZYME THERAPEUTICS, INC. SVP and Chief Medical Officer Sell 42.5 -6,900 -15.01% ✗ $84.6K
Jun 30, 2016 Jul 5, 2016 HALOZYME THERAPEUTICS, INC. SVP and Chief Medical Officer Sell 50.0 -107 -0.53% ✗ $923.4
Jan 5, 2016 Jan 7, 2016 HALOZYME THERAPEUTICS, INC. SVP and Chief Medical Officer Sell 42.5 -3,257 -19.28% ✗ $53.4K
Dec 31, 2015 Jan 4, 2016 HALOZYME THERAPEUTICS, INC. SVP and Chief Medical Officer Sell 95.0 +9,395 100.00% ✗ $98K